Literature DB >> 31267125

Leukocytoclastic Vasculitis Related to Ustekinumab in a Crohn's Disease Patient: First Case Report and Literature Review.

Pedro Costa-Moreira1,2, Susana Lopes1,3, Ana Luísa Santos1,2, Ana Filipa Pedrosa4, Patrícia Andrade1,2, Raquel Portugal3,2, Guilherme Macedo1,2.   

Abstract

Leukocytoclastic vasculitis is a single-organ, skin-isolated small vessel vasculitis. It can be a side effect of many common drugs, including biological agents. Unlike with other drugs, leukocytoclastic vasculitis induced by biological agents may have a prolonged latency period. We report the first case of ustekinumab-induced leukocytoclastic vasculitis in a patient with inflammatory bowel disease.
Copyright © 2019 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; Leukocytoclastic vasculitis; ustekinumab

Year:  2020        PMID： 31267125     DOI： 10.1093/ecco-jcc/jjz128

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


  5 in total

1.  Cutaneous Vasculitis During Secukinumab Treatment.

Authors:  Camila da Silva Cendon Duran; Mittermayer Barreto Santiago
Journal:  Eur J Case Rep Intern Med       Date:  2020-07-28

2.  Leukocytoclastic vasculitis as a rare dermatologic manifestation of Crohn's disease mimicking cellulitis: a case report.

Authors:  Meredith Buck; Igor Dumic; Wendy McDermott; Charles Nordstrom; Samarth Dawan; Andrew Virata; Scott Martin; Ann Hudson; Tamara Milovanovic; Terri Nordin
Journal:  BMC Gastroenterol       Date:  2020-07-29       Impact factor: 3.067

Review 3.  Clinical Manifestations of Leukocytoclastic Vasculitis, Treatment, and Outcome in Patients with Ulcerative Colitis: A Systematic Review of the Literature.

Authors:  Ivana Pantic; Djordje Jevtic; Charles W Nordstrom; Cristian Madrid; Tamara Milovanovic; Igor Dumic
Journal:  J Clin Med       Date:  2022-01-29       Impact factor: 4.241

Review 4.  Vasculitis induced by biological agents used in rheumatology practice: A systematic review.

Authors:  Camila da Silva Cendon Duran; Adriane Souza da Paz; Mittermayer Barreto Santiago
Journal:  Arch Rheumatol       Date:  2021-12-24       Impact factor: 1.007

Review 5.  The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges.

Authors:  Daniele Noviello; Riccardo Mager; Giulia Roda; Riccardo G Borroni; Gionata Fiorino; Stefania Vetrano
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.